International Patent: PROPHYLACTIC STEROID REGIMEN FOR RECOMBINANT ADENO-ASSOCIATED VIRAL VECTOR THERAPIES

GENEVA, Oct. 9 -- ABBVIE INC. filed a patent application (US2026/022311) for “PROPHYLACTIC STEROID REGIMEN FOR RECOMBINANT ADENO-ASSOCIATED VIRAL VECTOR THERAPIES”. With publication no. WO/2026/213546, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 38/18

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....